drugset / Trial / NCT05260255

Effect of Vitamin D Supplement on Disease Activity in SLE

NCT05260255 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

To study the effect of vitamin D supplementation on disease activity of SLE ( SLEDAI-2K ) and IL-6 level

Timeline

Start
2021-06-15
Primary completion
2022-05-01
Completion
2022-12-01

Outcome

Missed primary endpoint

paper CONCLUSION: Vitamin D3 supplementation up to 4,000 IU daily was safe and well-tolerated but failed to diminish the IFN signature in vitamin D-deficient SLE patients. PMID 25777546 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergocalciferol Small molecule 40000 iu —